Abstract Importance Although iron deficiency is common, it remains unclear which iron repletion strategy is associated with the lowest rate of infusion-related adverse events, and how patients with history of infusion reaction should be managed. Objective To evaluate rates of infusion reactions among...
An atypical adverse reaction to iron infusion: a case reportdoi:10.1007/s11739-024-03620-9Belviso, FabianaMarcianò, TeodoroSilva, MatteoSpringer International PublishingInternal & Emergency Medicine
Ten patients with active rheumatoid arthritis were given a total dose infusion of iron dextran for anaemia. One had an immediate anaphylactoid reaction; th... KN Lloyd,P Williams - 《British Medical Journal》 被引量: 45发表: 1970年 TOTAL DOSE INFUSION IRON DEXTRAN THERAPY IN PREDIALYSIS CHRON...
Major risk factors for hypersensitivity reactions include a previous reaction to an iron infusion, a fast iron infusion rate, multiple drug allergies, severe atopy, and possibly systemic inflammatory diseases. Early pregnancy is a contraindication to iron infusions, while old age and serious co-...
In a randomized, open-label, dose-ranging trial for Iron (Polysaccharide-Iron Complex) maintenance treatment with Iron (Polysaccharide-Iron Complex) in pediatric patients with CKD on stable erythropoietin therapy , at least one treatment-emergent adverse reaction was experienced by 57% (27/47) of ...
stable following completion of the infusion. Only administer Venofer when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Most reactions associated with intravenous iron preparations occur within 30 minutes of the completion of the infusion. ...
with parenteral iron as a second-line treatment in case there is intolerance or lack of response to oral iron. In patients with obesity with chronic low-grade inflammation and PMBS patients with altered gut anatomy and function, there are also alterations in the bioavailability and higher risks ...
The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the treatment and/or prophylaxis o
Only a single reaction to iron infusion has occurred. This was at the time of the first administration. The reaction was minor and occurred during the test dose period after about 5 minutes. The reaction was described as "uncomfortable flushing" of the face, but there were no ...
Taoguang Huo, in Biomedicine & Pharmacotherapy, 2023 5.1 Iron chelating agent Iron chelating agent is often used to treat iron overload in clinic. Desferramine (DFO), DFP and Deferasirox (DFX, ICL670) are usually used iron chelating agent in clinical for iron overload treatment. However, ...